Skip to main content


  • Caption

NPROXX scoops prestigious innovation award

13 November 2020

NPROXX has been awarded the ‘2020 AC2 Innovation Prize, District of Aachen’ for the development of carbon fibre high pressure storage vessels for gaseous hydrogen storage.

NPROXX is a subsidiary of Urenco’s joint venture Enrichment Technology Company (ETC), and both NPROXX and ETC are focussed on technological advancement.

Weight and product quality are what set NPROXX’s storage vessels apart from conventional products. As a result, they are ideally suited for future vehicle production and transport solutions. NPROXX is currently working on expanding its manufacturing capacity.

Dr. Rainer vor dem Esche, Managing Director of NPROXX (pictured), said: “We are very proud to have been awarded this prize. The mobility of the future has begun! Our region is at the forefront. We, as NPROXX, would like to do our part with our storage solutions. We see this prize as motivation for the future, but also as appreciation for the work we have done."

Read more about NPROXX


About Urenco

Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.

With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.

Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.


Sign up to our newsletter by entering your email address below.

Back to
the goals